
News|Podcasts|May 12, 2025
Insights from a Pharmacy Times Peer Exchange: Emerging ADCs and Real-World Management
Explore the latest insights on emerging antibody drug conjugates for HER2 breast cancer and real-world management strategies.
Advertisement
In this episode of the Pharmacy Times Peer Exchange feature series about antibody drug conjugates (ADCs) and human epidermal growth factor receptor 2 (HER2) breast cancer (BC), oncology pharmacists discuss novel, emerging ADCs and real-world management of these therapies.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Obinutuzumab-Bendamustine Produces High Response Rates in Chinese Patients With Indolent B-Cell Lymphomas
2
State Pharmacy Boards Must Step Up Against Illegal Retatrutide
3
Long-Lived Monocyte-Derived Cells Found to Support Lasting Lung Immunity Against Influenza
4
What Pharmacists Should Know About the Ifosfamide Shortage
5





































































































